Can repeated intranasal oxytocin administration affect reduced neural sensitivity towards expressive faces in autism? A randomized controlled trial.

BRAIN physiology; OXYTOCIN; RESEARCH; STATISTICS; FACIAL expression; RANDOMIZED controlled trials; INTRANASAL administration; AUTISM; DESCRIPTIVE statistics; BLIND experiment; COMMUNICATION; RESEARCH funding; DATA analysis software; SOCIAL skills; DATA analysis; DISEASE complications

Background: Autism spectrum disorder (ASD) is a neurodevelopmental condition characterized by difficulties in social communication and interaction. Crucial for efficient social interaction is the ability to quickly and accurately extract information from a person's face. Frequency‐tagging electroencephalography (EEG) is a novel tool to quantify face‐processing sensitivity in a robust and implicit manner. In terms of intervention approaches, intranasal administration of oxytocin (OT) is increasingly considered as a potential pharmacological approach for improving socio‐communicative difficulties in ASD, through enhancing social salience and/or reducing (social) stress and anxiety. Methods: In this randomized, double‐blind, placebo‐controlled, mechanistic pharmaco‐neuroimaging clinical trial, we implemented frequency‐tagging EEG to conduct an exploratory investigation into the impact of repeated OT administration (4 weeks, 12 IU, twice daily) on neural sensitivity towards happy and fearful facial expressions in children with ASD (8–12 years old; OT: n = 29; placebo: n = 32). Neural effects were assessed at baseline, post‐nasal spray (24 hr after the last nasal spray) and at a follow‐up session, 4 weeks after the OT administration period. At baseline, neural assessments of children with ASD were compared with those of an age‐ and gender‐matched cohort of neurotypical (NT) children (n = 39). Results: Children with ASD demonstrated reduced neural sensitivity towards expressive faces, as compared to NT children. Upon nasal spray administration, children with ASD displayed a significant increase in neural sensitivity at the post‐ and follow‐up sessions, but only in the placebo group, likely reflecting an implicit learning effect. Strikingly, in the OT group, neural sensitivity remained unaffected from the baseline to the post‐session, likely reflecting a dampening of an otherwise typically occurring implicit learning effect. Conclusions: First, we validated the robustness of the frequency‐tagging EEG approach to assess reduced neural sensitivity towards expressive faces in children with ASD. Furthermore, in contrast to social salience effects observed after single‐dose administrations, repeated OT administration dampened typically occurring learning effects in neural sensitivity. In line with OT's social anxiolytic account, these observations possibly reflect a predominant (social) stress regulatory effect towards emotionally evocative faces after repeated OT administration. [ABSTRACT FROM AUTHOR]

Copyright of Journal of Child Psychology is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)